Abiopharma

🔍 Schenk Chris (Executive)

Company: Ategrity Specialty Insurance Co Holdings (ASIC)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Acquired 21,981 shares of Stock Option (right to buy) at $10.66 per share (Derivative)
  Date: 2026-03-05 | Code: A | Expires: 2032-01-01 | Exercise: 2026-03-05 | equity_swap_involved: 0 | shares_owned_after: 21,981.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: On January 1, 2022 the reporting person was granted an option to purchase 43,963 shares of common stock. 50% of the option was eligible to vest as of January 1, 2026 based on the Issuer's satisfaction of certain performance criteria for the two fiscal years immediately preceding the vesting date. The performance criteria for 2024 and 2025 were met, resulting in the vesting of the option as to 21,981 shares.
• REMARKS: President, Chief Underwriting Officer